Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57) - Image 1

£148.69

Springer Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Name: Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Brand: Springer
Price: 148.69 GBP
Availability: InStock

Oncology

This is the usual price. Wait for it to drop, or tell us your number.

£149 today · usual range £0–£0 · best ever £140

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 584 days • 584 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 584 days • 7 price levels

Days at Price

Current Price

Price Analysis

Most common price: £140 (308 days, 52.7%)

Price range: £140 - £180

Price levels: 7 different prices over 584 days

Description

The importance of drug resistance in cancer chemotherapy cannot be over stated. The 500,000 patients who die every year from cancer in the United States have, in most cases, been treated with chemotherapy. Many of these patients responded initially to chemotherapy, but death resulted from the development of drug-resistant tumors. In the first volume in the series. Drug Resistance in Chemotherapy the results of comprehensive laboratory studies aimed at understanding the mechanisms for resistance to individual agents and to the development of broad cross-resistance were described. In the past 2 years there has been substantial progress in understanding the molecular biology associated with these mechanisms of drug resistance. For the first time we are starting to understand which mechanisms are playing an im portant role in human tumors, and even more importantly, clinical trials have recently been initiated in an effort to reverse specific forms of drug resistance. The purpose of this volume is to describe the new advances, both at the molecular level and in the clinic regarding mechanisms of drug resistance and potential ways this resistance can be circumvented. This volume is focused upon mechanisms of resistance associated with two major classes of anticancer drugs: alkylating agents (including cisplatin) and the natural products (e. g. , adriamycin and vinblastine). The first section of the book describes new insights into the genetic mechanisms associated with drug resistance. Review ' This book contains much valuable information, including an extensive bibliography. As such, it is primarily of value as a reference text both for clinical and basic scientific research staff. ' Journal of the National Cancer Institute 84:22 1992 'This book would be a helpful text for basic researchers, clinical investigators, and medical housestaff. It is well written and can be read in a relatively short period of time. ' Breast Cancer Research and Treatment 19 1991

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1461367263
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Publication Date: 05 November 2012
Listed Since: 03 March 2013

Barcode

No barcode data available

Springer Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Drug Resistance in Cancer Cells

Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)

Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Cancer Cell Chemoresistance And Chemosensitization

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Cancer Chemotherapy: Basic Science to the Clinic

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Springer - Molecular Mechanisms of Tumor Cell Resistance

Apoptosis and Cancer Chemotherapy (Cancer Drug Discovery and Development)

Academic Press pH-Interfering Agents in Cancer Therapy Vol 10

The Chemistry of Antitumour Agents

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)

Nitric Oxide (Donor/Induced) in Chemosensitization (Volume 1) (Cancer Sensitizing Agents for Chemotherapy, Volume 1)

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies